Bendamustine and Obinutuzumab
About
Membership operator: AND
Therapies: 2
Therapies
Bendamustine (tx:ncit:C73261)
Obinutuzumab (tx:ncit:C70741)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| HSE (2) | CD20 + | Follicular Lymphoma | Bendamustine, Obinutuzumab |